All-Star Players

Wall Street

Top FMI Bull/Bear Pitches

Submitted September 03, 2014

Foundation Medicine runs high-speed genomic tests to profile individual patients, identify genetic abnormalities, and then recommend the best course of action for their treatment. I expect them to benefit from continued adoption of personalized… More

A leader in the push to personalized genetic medicine at a much earlier stage due to the market niche. Foundation already has a strong industry partner in Roche and if they don't explode on their own they may be acquired. It's riskier, but could be a multi-bagger.